Skip to main content
logo
LB Pharmaceuticals Inc (LBRX)
NASDAQ: LBRX · Real-Time Price · USD
47.78
+0.68 (1.44%)
Sep 2, 2026, 9:54 AM EDT - Market open

LB Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Market Capitalization
1,541563---
Market Cap Growth
-----
Enterprise Value
1,219252---
Last Close Price
47.1022.26---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
PB Ratio
4.061.87---
P/TBV Ratio
4.571.87---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
0.020.010.19--1.12
Net Debt / Equity Ratio
-0.97-0.97-1.23-1.04-0.13
Net Debt / EBITDA Ratio
3.549.990.383.81-0.98
Net Debt / FCF Ratio
3.898.270.453.57-1.01
Quick Ratio
13.9139.673.4516.6145.64
Current Ratio
15.0841.453.5617.5145.82
Return on Equity (ROE)
-50.00%-15.70%-206.22%-63.14%-
Return on Assets (ROA)
-29.98%-10.64%-102.33%-21.18%-
Return on Capital Employed (ROCE)
-27.00%-9.70%-255.00%-26.40%-13.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Earnings Yield
-5.64%-4.48%---
FCF Yield
-5.45%-6.26%---
Buyback Yield / Dilution
-8821.45%-2145.81%-43.52%-8.02%-
SEC Filings: 10-K · 10-Q